drugset / Trial / NCT00206063
Long Term Open Follow-up With H376/95 vs. Warfarin
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate tolerability of long-term treatment with ximelagatran compared to standard treatment with warfarin.
Timeline
- Start
- 1999-08
- Primary completion
- 2004-06
- Completion
- 2006-04
Outcome
Outcome not reported
Stopped: “Melagatran/ximelagatran was withdrawn from the market and clinical development in February 2006 in the interest of patient safety.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ximelagatran | Small molecule | — | Oral |
Indications
No indication recorded.